76 results on '"Finolezzi, E"'
Search Results
2. P060 - Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: KENNEDY’S DISEASE AND MYELODISPLASTIC SYNDROME: A POSSIBLE NEW ENTITY IN MYELOID NEOPLASM GERMLINE PREDISPOSITION. A CASE REPORT
3. Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography
4. New category of probable invasive pulmonary aspergillosis in haematological patients
5. New category of probabile invasive pulmonary aspergillosis in hematologic malignancies
6. Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes
7. MACOP-B +/- RITUXIMAB FOLLOWED BY INVOLVED MEDIASTINAL RADIOTHERAPY IS A SAFE AND HIGH EFFECTIVE THERAPY FOR PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA (PMBL): LONG TERM RESULTS AND LATE TOXICITY FROM A SINGLE ITALIAN CENTER
8. NODAL AND NON-NODAL MANTLE CELL LYMPHOMAS DISPLAY A DIFFERENT GENOMIC PROFILE AND IGHV MUTATIONAL STATUS
9. GENOMIC PROFILE OF NON-NODAL MANTLE CELL LYMPHOMA IS CHARACTERIZED BY A DOWN-MODULATION OF GENES INVOLVED IN TUMOR INVASION
10. DOSE-DENSE THERAPY (R-CHOP14) SEEMS TO OVERCOME THE NEGATIVE PROGNOSTIC SIGNIFICANCE OF B CELL ORIGIN IN DLBCL LYMPHOMA PATIENTS
11. RITUXIMAB-CHOP14 SEEMS TO OVERCOME THE NEGATIVE PROGNOSTIC SIGNIFICANCE OF B CELL ORIGIN IN DLBCL LYMPHOMA PATIENTS
12. Rituximab combined with M/VACOP-B and radiotherapy in primary mediastinal large B-cell lymphoma (PMLBCL): A prospective italian phase II study of Intergruppo Italiano Linfomi (IIL)
13. The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial
14. Rituximab plus dose-dense CHOP (RCHOP-14) for the treatment of patients with aggressive lymphoma
15. Primary mediastinal large B cell lymphoma with sclerosis: A clinical study of 92 patients treated at a single institution with macop-B and radiotherapy
16. MITRAL VALVE INVOLVEMENT IN PRIMARI ANTIPHOSPHOLIPID SINDROME
17. Cisplatinum, idarubicin, prednisone (CIP) after P-VABEC chemotherapy improves survival in elderly patients with diffuse large cell lymphoma: Long term follow-up
18. Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia
19. ARSENIC TRIOXIDE IN THE TREATMENT OF ADVANCED ACUTE PROMYELOCYTIC LEUKEMIA (APL)
20. Anthracycline cardiotoxicity
21. MYELODYSPLASTIC SYNDROMES (MDS) WITH NORMAL KARYOTYPE: IDENTIFICATION OF CLINICAL FEATURES OF PROGNOSTIC SIGNIFICANCE FOR RISK OF TRANSFORMATION
22. INCREASED RISK OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA RECEIVING ATRA TREATMENT
23. The antineoplastic treatment in the elderly
24. [The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient]
25. Prevenzione dell'emesi da chemioterapia antiblastica nel paziente oncologico anziano [The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient]
26. Impact of Dose-Dense Immunochemotherapy on Prognosis of Germinal Center and Non Germinal Center Origin of Diffuse Large B Cell Lymphoma
27. Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.
28. Systematic Radical Gastrectomy and D2 Lymphadenectomy in Primary Gastric B Cell Lymphoma: Impact on Diagnosis, Classification and Long Term Results. A Prospective Study
29. Prevention of radiotherapy-induced emesis
30. Therapeutic advances in neoplastic hematology: Target therapy anti-CD33,Approcci terapeutici innovativi in oncoematologia: Terapia mirata anti-CD33
31. R-CHOP21 VS R-CHOP14 IN 1024 DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: RESULTS FROM A MULTICENTRE RETROSPECTIVE STUDY OF FONDAZIONE ITALIANA LINFOMI (FIL)
32. Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemia
33. Anthracycline cardiotoxicity | Cardiotossicità da antracicline
34. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography
35. Gemtuzumab Ozogamicin (Mylotarg) as a single agent for moleculary relapsed acute promyelocytic leukemia
36. The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: A seven-year update of the GIMEMA 0496 trial
37. Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant.
38. MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL).
39. Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
40. Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study.
41. Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma.
42. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
43. Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.
44. Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review.
45. Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
46. Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options.
47. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
48. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
49. Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.
50. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.